.png)
Lighthouse
Why Cancer Survival in the US Is Better Than in the UK
Cancer mortality data consistently favor people in the US versus their UK counterparts for a variety of reasons.
top of page
Lighthouse
Why Paint from a Limited Palette in Cancer Clinical Trials?
Quality of Life as an outcome in cancer clinical trials is an often overlooked but key aspect of the outcome of new cancer treatments.
Lighthouse
The Importance and Underuse of Germline Testing
Germline testing for inherited genetic variants is recommended to many people with cancer, yet such useful testing is notably underutilized.
Lighthouse
MSLs: The Value of Local Knowledge
Medical Science Liaisons are vital to foster relationships with HCPs, educating them about new treatments, and implementing clinical trials.
Lighthouse
Hashtag Cancer: Social Media and Oncology
Most Americans use social media, making it a crucial tool in oncology, where new findings, biomarkers, treatments, and trials are presented.
Lighthouse
Shark Bites and Cancer Clinical Trials
Education about cancer clinical trials can increase trial enrollment by improving impressions, reducing fears, and raising awareness.
Lighthouse
The Benefit of Patient Navigators in Cancer Clinical Trials
Patient Navigators increase the awareness and knowledge of people with cancer about clinical trials, leading to improved enrollment rates.
Lighthouse
Single-Gene Testing vs. NGS: Seeking One Target or Many
Choosing NGS first rather than Single-Gene Testing in cancer is a financially effective and diagnostically efficient strategy in many cases.
Lighthouse
Raising Awareness of New Targeted Oncology Clinical Trials
To enroll in clinical trials for targeted cancer therapies, people must be aware of them; thus, raising awareness is vital to enrollment.
Lighthouse
Including Rural Patients in Cancer Clinical Trials
Rural patients are underrepresented in cancer clinical trials, yet there are many steps to increase rural cancer trial participation rates.
Lighthouse
The Post-COVID Shift to Patient-Centric Cancer Clinical Trials
After the COVID-19 pandemic, cancer clinical trials adopted a more patient-centric approach where trials work better for participants.
Lighthouse
Diversity in Cancer Clinical Trials: Issues and Solutions
Cancer clinical trial diversity is poor, which matters because of different treatment responses. Solutions are vital to improve trials.
Lighthouse
Clinical Trial Delays in Europe after New Diagnostic Device Regulation
Half of all EU clinical trials are currently running behind schedule due to problems with new regulations for diagnostic medical devices.
Lighthouse
Three CMO Need-to-Knows about Clinical Trial Awareness
A CMO is responsible for compound development success, so building awareness proactively and compliantly is critical for clinical trials.
Lighthouse
Learning from Clinical Trial Failures
Clinical trial failures are common and costly, yet they can teach us important lessons.
Lighthouse
Clinical Trial Problems in the United Kingdom
Clinical trials held in the UK have seen patient enrollment and trial numbers drop. Flexibility & creativity are needed to overcome issues.
Lighthouse
Blood-based Biomarkers in Alzheimer’s Disease
Blood-based biomarkers (BBMs) hold promise for a fast, convenient, and simple means to accurately diagnose Alzheimer's Disease.
Lighthouse
The New European Clinical Trials Information System
The European Medicines Agency (EMA) began mandatory use of the new Clinical Trials Information System (CTIS) as of Tuesday, Jan. 31, 2023.
Lighthouse
Decision-making for Cancer Clinical Trial Participants
Making decisions about medical treatment can be challenging and stressful. Furthermore, challenge and stress are magnified when deciding...
Lighthouse
Four Facets of Ethics in Cancer Clinical Trials
The development of life-saving treatments depends on clinical trials, which rely on ethical guidelines to ensure participants' safety.
bottom of page